EUVIMEDEUVIMED entdecken
Systematische Übersicht

Successful Treatment of Recurrent Lymphocytic Hypophysitis with Fractionated Stereotactic Radiotherapy: A Single-Center Experience and Systematic Literature Review

Mehdi Khaleghi, Guilherme Finger, Kyle Wu, Vikas Munjal, Luma Ghalib, Peter Kobalka, Dukagjin Blakaj, Ricardo Carrau, Daniel Prevedello

Journal of Neurological Surgery Part B: Skull Base · 01.02.2024 · 85 (S 01 S 01) · S1-S398

DOI: 10.1055/s-0044-1779975 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Neurological Surgery Part B: Skull Base, erschienen am 01.02.2024. Verfasst von Mehdi Khaleghi und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Lymphocytic hypophysitis (LH) is a rare autoimmune inflammation of the pituitary gland with clinical and radiologic features mimicking pituitary adenomas. While glucocorticoids and surgery are the primary treatments, focused radiotherapy can be a viable alternative, particularly in refractory cases. The authors report their institutional experience with the successful treatment of refractory LH in three patients using fractionated stereotactic radiotherapy (FSRT) and provide a systematic literature review to explore the potential role of focused radiotherapy in treatment.

Methods

A systematic literature review was conducted following PRISMA guidelines to identify all English-language studies on radiation treatment for hypophysitis in PubMed, Embase, and Scielo databases, along with the institutional database for the cases with refractory hypophysitis defined as the lack of sustained clinical or radiologic response to either glucocorticoid therapy or surgery during at least a 12-month follow-up. Post-radiation neurologic outcomes were assessed using the Glasgow Outcome Scale (GOS). A “complete clinical response” was defined as the sustained resolution of pre-radiation clinical symptoms while on low-dose glucocorticoid or a sustained GOS grade of 5 following FSRT completion. A complete shrinkage of the associated sellar/suprasellar mass through follow-up MRIs was considered a “complete radiologic response,” while a stable mass size or partial shrinkage was defined as “partial radiologic response.” Patient demographics, treatment details, and follow-up outcomes were extracted for analysis.

Results

The study included eight patients comprising five women and three men. The age at presentation ranged from 37 to 75 years, with a median age of 58. Initial medical treatment in all patients involved oral glucocorticoid, with three patients (37%) necessitating high doses and two patients (25%) required immunosuppressive therapy before radiation. Seven patients (87.5%) had a history of transsphenoidal surgery confirmed as LH through histologic study. Two patients (25%) underwent craniotomy, and two patients (25%) had at least three surgeries through a transsphenoidal approach. Three patients (37%) underwent stereotactic radiosurgery (SRS), while the remaining received FSRT. The irradiation volume ranged from 0.41 to 3.94 cm 3 , with a mean volume of 2.2 cm 3 . In the SRS group, a single-session total dose of 12 or 15 Gy was administered, while the FSRT group received doses ranging from 24 to 30 Gy with a median dose of 25 Gy, delivered in 2 Gy fractions. Complete clinical response was achieved in seven patients (87.5%) after one radiation course, and one patient achieved it after a second course. Six patients remained stable on low-dose prednisolone, and one discontinued it entirely without experiencing relapse during a 12-month follow-up period. Three patients (37%), including two from the SRS group and one from the FSRT group, demonstrated a complete radiologic response, while the remaining showed a partial radiologic response.

Conclusions

Diverse presentations and treatment responses are generally expected in LH. FSRT has emerged as a promising treatment option for refractory LH, offering long-term disease control while minimizing radiation exposure to nearby critical structures. However, comprehensive studies on FSRT are necessary to determine the long-term effects, optimal dose planning, and patient selection criteria, solidifying its role as a standard treatment ([ Figs. 1 ]–[ 4 ]). Fig. 1 Fig. 2 Fig. 3 Fig. 4 Publication History Article published online: 05 February 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Zitieren

APA

Khaleghi, M., Finger, G., Wu, K., Munjal, V., Ghalib, L., Kobalka, P., Blakaj, D., Carrau, R., & Prevedello, D. (2024). Successful Treatment of Recurrent Lymphocytic Hypophysitis with Fractionated Stereotactic Radiotherapy: A Single-Center Experience and Systematic Literature Review. Journal of Neurological Surgery Part B: Skull Base, 85(S 01 S 01), S1-S398. https://doi.org/10.1055/s-0044-1779975

Vancouver

Khaleghi M, Finger G, Wu K, Munjal V, Ghalib L, Kobalka P, et al. Successful Treatment of Recurrent Lymphocytic Hypophysitis with Fractionated Stereotactic Radiotherapy: A Single-Center Experience and Systematic Literature Review. Journal of Neurological Surgery Part B: Skull Base. 2024;85(S 01 S 01):S1-S398. doi:10.1055/s-0044-1779975

BibTeX
@article{Khaleghi2024,
  author = {Khaleghi, Mehdi and Finger, Guilherme and Wu, Kyle and Munjal, Vikas and Ghalib, Luma and Kobalka, Peter and Blakaj, Dukagjin and Carrau, Ricardo and Prevedello, Daniel},
  title = {Successful Treatment of Recurrent Lymphocytic Hypophysitis with Fractionated Stereotactic Radiotherapy: A Single-Center Experience and Systematic Literature Review},
  journal = {Journal of Neurological Surgery Part B: Skull Base},
  year = {2024},
  volume = {85},
  number = {S 01 S 01},
  pages = {S1--S398},
  doi = {10.1055/s-0044-1779975}
}
Kostenlos starten →